Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00326222
Other study ID # PASOPP1
Secondary ID
Status Completed
Phase N/A
First received May 15, 2006
Last updated July 18, 2016
Start date May 2006
Est. completion date November 2008

Study information

Verified date July 2016
Source Norwegian University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority Norway: Norwegian Social Science Data Services
Study type Interventional

Clinical Trial Summary

The purpose of this randomised open study is to examine the effect of self-management program for diabetes patients.


Description:

The primary aim in this study is HbA1c in addition to secondary aims like quality of life and coping.


Recruitment information / eligibility

Status Completed
Enrollment 146
Est. completion date November 2008
Est. primary completion date November 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Diagnosed with ICPC-2, code T89 - diabetes dependent on insulin and T90 diabetes not dependent on insulin

Exclusion Criteria:

- Diagnosed with ICPC-2, code T89 - diabetes mellitus juvenile and diabetes I

- Attended self-management program previous 12 months

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Behavioral:
Lifestyle counseling
Self-management group education

Locations

Country Name City State
Norway Nord-Trondelag Hospital Trust Levanger Nord-Trondelag

Sponsors (2)

Lead Sponsor Collaborator
Norwegian University of Science and Technology Central Norway Regional Health Authority

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Rygg LØ, Rise MB, Grønning K, Steinsbekk A. Efficacy of ongoing group based diabetes self-management education for patients with type 2 diabetes mellitus. A randomised controlled trial. Patient Educ Couns. 2012 Jan;86(1):98-105. doi: 10.1016/j.pec.2011.04 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary HbA1c Baseline, 6, and 12 mds No
Primary PAM - Patient activation measure Baseline, 6, and 12 mds No
Secondary SF36 Baseline, 6, and 12 mds No
Secondary EQ 5D-VAS scale Baseline, 6, and 12 mds No
Secondary Hunt diabetes Baseline, 6, and 12 mds No
Secondary WHO-DTSQ Baseline, 6, and 12 mds No
Secondary Knowledge of diabetes Baseline, 6, and 12 mds No
Secondary HDL-cholesterol Baseline, 6, and 12 mds No
Secondary Total cholesterol Baseline, 6, and 12 mds No
Secondary Creatinin Baseline, 6, and 12 mds No
Secondary Blood pressure Baseline, 6, and 12 mds No
Secondary Weight Baseline, 6, and 12 mds No
Secondary BMI Baseline, 6, and 12 mds No
Secondary Cost/benefit Baseline, 6, and 12 mds No
Secondary Triglyceride Baseline, 6, and 12 mds No
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A